Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Arrhythmias

  Free Subscription


Articles published in Circulation

Retrieve available abstracts of 218 articles:
HTML format
Text format



Single Articles


    March 2017

  1. Correction to: Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy.
    Circulation. 2017;135:e789.
    PubMed     Text format    


  2. LINDNER SM, Fordyce CB, Hellkamp AS, Lokhnygina Y, et al
    Treatment Consistency Across Levels of Baseline Renal Function With Rivaroxaban or Warfarin: A ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atria
    Circulation. 2017;135:1001-1003.
    PubMed     Text format    


    February 2017
  3. HYLTEN-CAVALLIUS L, Iepsen EW, Wewer Albrechtsen NJ, Svendstrup M, et al
    Patients with Long QT Syndrome Due to Impaired hERG-encoded Kv11.1 Potassium Channel Have Exaggerated Endocrine Pancreatic and Incretin Function Associated with Reactive Hypoglycemia.
    Circulation. 2017 Feb 24. pii: CIRCULATIONAHA.116.024279.
    PubMed     Text format     Abstract available


  4. PARKASH R, Wells GA, Sapp JL, Healey JS, et al
    The Effect of Aggressive Blood Pressure Control on the Recurrence of Atrial Fibrillation After Catheter Ablation: A Randomized, Open Label, Clinical Trial (Substrate Modification with Aggressive Blood Pressure Control: SMAC- AF).
    Circulation. 2017 Feb 22. pii: CIRCULATIONAHA.116.026230.
    PubMed     Text format     Abstract available



  5. Correction to: Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study.
    Circulation. 2017;135:e48.
    PubMed     Text format    


  6. SIONTIS KC, Yao X, Gersh BJ, Noseworthy PA, et al
    Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease Other Than Significant Mitral Stenosis and Mechanical Valves: A Meta-Analysis.
    Circulation. 2017;135:714-716.
    PubMed     Text format    


  7. WONG JA, Rexrode KM, Sandhu RK, Conen D, et al
    Number of Pregnancies and Atrial Fibrillation Risk: The Women's Health Study.
    Circulation. 2017;135:622-624.
    PubMed     Text format    


  8. GILLIS AM
    Atrial Fibrillation and Ventricular Arrhythmias: Sex Differences in Electrophysiology, Epidemiology, Clinical Presentation, and Clinical Outcomes.
    Circulation. 2017;135:593-608.
    PubMed     Text format     Abstract available


  9. FREEMAN JV, Wang Y, Akar JG, Desai N, et al
    National Trends in Atrial Fibrillation Hospitalization, Readmission,and Mortality for Medicare Beneficiaries, 1999-2013.
    Circulation. 2017 Feb 1. pii: CIRCULATIONAHA.116.022388.
    PubMed     Text format     Abstract available


    January 2017
  10. HESS PL, Hernandez AF, Bhatt DL, Hellkamp AS, et al
    Response by Hess et al to Letter Regarding Article, "Sex and Race/Ethnicity Differences in Implantable Cardioverter-Defibrillator Counseling and Use Among Patients Hospitalized With Heart Failure: Findings From the Get With The Guidelines-Heart Failur
    Circulation. 2017;135:e22-e23.
    PubMed     Text format    


  11. DHRUVA SS, Redberg RF
    Letter by Dhruva and Redberg Regarding Article, "Sex and Race/Ethnicity Differences in Implantable Cardioverter-Defibrillator Counseling and Use Among Patients Hospitalized With Heart Failure: Findings From the Get With The Guidelines-Heart Failure Pr
    Circulation. 2017;135:e20-e21.
    PubMed     Text format    


  12. NIELSEN PB, Lip GY
    Adding Rigor to Stroke Rate Investigations in Patients With Atrial Fibrillation.
    Circulation. 2017;135:220-223.
    PubMed     Text format    


  13. LINK MS, Haissaguerre M, Natale A
    Response by Link et al to Letter Regarding Article, "Ablation of Atrial Fibrillation: Patient Selection, Periprocedural Anticoagulation, Techniques, and Preventive Measures After Ablation".
    Circulation. 2017;135:e3-e4.
    PubMed     Text format    


  14. MAESEN B, Pison L, Meir M
    Letter by Maesen et al Regarding Article, "Ablation of Atrial Fibrillation: Patient Selection, Periprocedural Anticoagulation, Techniques, and Preventive Measures After Ablation".
    Circulation. 2017;135:e1-e2.
    PubMed     Text format    


  15. CHAN PH, Wong CK, Pun L, Wong YF, et al
    Head-to-Head Comparison of the AliveCor Heart Monitor and Microlife WatchBP Office AFIB for Atrial Fibrillation Screening in a Primary Care Setting.
    Circulation. 2017;135:110-112.
    PubMed     Text format    


  16. HAMPTON T
    Handheld Technologies May Lead to Better Detection of Atrial Fibrillation.
    Circulation. 2017;135:108-109.
    PubMed     Text format    


    December 2016
  17. GOLWALA H, Bajaj NS, Arora G, Arora P, et al
    Implantable Cardioverter-Defibrillator for Non Ischemic Cardiomyopathy: An Updated Meta-Analysis.
    Circulation. 2016 Dec 19. pii: CIRCULATIONAHA.116.026056.
    PubMed     Text format     Abstract available


  18. CHATTERJEE NA, Giulianini F, Geelhoed B, Lunetta KL, et al
    Genetic Obesity and the Risk of Atrial Fibrillation- Causal Estimates from Mendelian Randomization.
    Circulation. 2016 Dec 14. pii: CIRCULATIONAHA.116.024921.
    PubMed     Text format     Abstract available


  19. LI N, Hansen BJ, Fedorov VV
    Response by Li et al to Letter Regarding Article, "Adenosine-Induced Atrial Fibrillation: Localized Reentrant Drivers in Lateral Right Atria Due to Heterogeneous Expression of Adenosine A1 Receptors and GIRK4 Subunits in the Human Heart".
    Circulation. 2016;134:e648-e649.
    PubMed     Text format    


  20. HE YM
    Letter by He Regarding Article, "Adenosine-Induced Atrial Fibrillation: Localized Reentrant Drivers in Lateral Right Atria Due to Heterogeneous Expression of Adenosine A1 Receptors and GIRK4 Subunits in the Human Heart".
    Circulation. 2016;134:e647.
    PubMed     Text format    


    November 2016
  21. MELDUNI RM, Schaff HV, Lee HC, Gersh BJ, et al
    Impact of Left Atrial Appendage Closure During Cardiac Surgery on the Occurrence of Early Postoperative Atrial Fibrillation, Stroke, and Mortality: A Propensity Score Matched Analysis of 10,633 Patients.
    Circulation. 2016 Nov 30. pii: CIRCULATIONAHA.116.021952.
    PubMed     Text format     Abstract available


  22. POKORNEY SD, Miller AL, Chen AY, Thomas L, et al
    Reassessment of Cardiac Function and Implantable Cardioverter-Defibrillator Use Among Medicare Patients with Low Ejection Fraction After Myocardial Infarction.
    Circulation. 2016 Nov 16. pii: CIRCULATIONAHA.116.022359.
    PubMed     Text format     Abstract available


  23. GIBSON CM, Pinto DS, Chi G, Arbetter D, et al
    Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy.
    Circulation. 2016 Nov 14. pii: CIRCULATIONAHA.116.025783.
    PubMed     Text format     Abstract available


  24. HALPERIN JL, Savino JA 3rd
    Response by Halperin and Savino to Letter Regarding Article, "Should Patients with Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? The CHA2DS2-VASc 1 Conundrum: Decision Making at the Lower End
    Circulation. 2016;134:e391-e392.
    PubMed     Text format    


  25. NIELSEN PB, Lip GY
    Response by Nielsen and Lip to Letter Regarding Article, "Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? Yes: Even 1 Stroke Risk Factor Confers a Real Risk of Stroke".
    Circulation. 2016;134:e389-e390.
    PubMed     Text format    


  26. ASINGER RW, Shroff GR, Herzog CA
    Letter by Asinger et al Regarding Articles, "Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? Yes: Even 1 Stroke Risk Factor Confers a Real Risk of Stroke" and "Should Patie
    Circulation. 2016;134:e387-e388.
    PubMed     Text format    


    October 2016
  27. QUINN GR, Severdija ON, Chang Y, Singer DE, et al
    Wide Variation in Reported Rates of Stroke Across Cohorts of Patients with Atrial Fibrillation.
    Circulation. 2016 Oct 31. pii: CIRCULATIONAHA.116.024057.
    PubMed     Text format     Abstract available


  28. LUBITZ SA, Yin X, Lin H, Kolek M, et al
    Genetic Risk Prediction of Atrial Fibrillation.
    Circulation. 2016 Oct 28. pii: CIRCULATIONAHA.116.024143.
    PubMed     Text format     Abstract available


  29. FENDER EA, Widmer RJ, Hodge DO, Cooper GM, et al
    Severe Pulmonary Vein Stenosis Resulting from Ablation for Atrial Fibrillation: Presentation, Management and Clinical Outcomes.
    Circulation. 2016 Oct 28. pii: CIRCULATIONAHA.116.021949.
    PubMed     Text format     Abstract available


  30. SWIRYN S, Orlov MV, Benditt DG, DiMarco JP, et al
    Clinical Implications of Brief Device-Detected Atrial Tachyarrhythmias in a Cardiac Rhythm Management Device Population: Results from the Registry of Atrial Tachycardia and Atrial Fibrillation Episodes.
    Circulation. 2016;134:1130-1140.
    PubMed     Text format     Abstract available


  31. KATRITSIS DG, Marine JE, Contreras FM, Fujii A, et al
    Catheter Ablation of Atypical Atrioventricular Nodal Reentrant Tachycardia.
    Circulation. 2016 Oct 17. pii: CIRCULATIONAHA.116.024471.
    PubMed     Text format     Abstract available


    September 2016
  32. WIJESURENDRA RS, Liu A, Eichhorn C, Ariga R, et al
    "Lone" Atrial Fibrillation Is Associated With Impaired Left Ventricular Energetics That Persist Despite Successful Catheter Ablation.
    Circulation. 2016 Sep 14. pii: CIRCULATIONAHA.116.022931.
    PubMed     Text format     Abstract available


  33. HYMAN MC, Callans DJ
    Mental Exit Block: Escaping the Pulmonary Veins in Search of New Approaches to Atrial Fibrillation Management.
    Circulation. 2016 Sep 14. pii: CIRCULATIONAHA.116.024636.
    PubMed     Text format     Abstract available


  34. CHAO TF, Liu CJ, Liao JN, Wang KL, et al
    Response by Chao et al to Letters Regarding Article, "Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage".
    Circulation. 2016;134:e230-1.
    PubMed     Text format    


  35. YANG X, An R, Xu Y
    Letter by Yang et al Regarding Article, "Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage".
    Circulation. 2016;134:e228-9.
    PubMed     Text format    


  36. CHAN PH, Siu CW
    Letter by Chan and Siu Regarding Article, "Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage".
    Circulation. 2016;134:e226-7.
    PubMed     Text format    


  37. DI BIASE L, Mohanty P, Mohanty S, Santangeli P, et al
    Response by Di Biase et al to Letter Regarding Article, "Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial"
    Circulation. 2016;134:e189-90.
    PubMed     Text format    


  38. SKOLNIK N
    Letter from Skolnik Regarding Article, "Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial".
    Circulation. 2016;134:e187-8.
    PubMed     Text format    


  39. LIU W, Yang XJ
    Letter from Liu and Yang Regarding Article, "Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial".
    Circulation. 2016;134:e185-6.
    PubMed     Text format    


  40. KOSIUK J, Hindricks G, Bollmann A
    Letter from Kosiuk et al Regarding Article, "Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial".
    Circulation. 2016;134:e183-4.
    PubMed     Text format    


  41. WILLEY JZ, Biviano A
    Letter from Willey and Biviano Regarding Article, "Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial".
    Circulation. 2016;134:e181-2.
    PubMed     Text format    


  42. TURCO P
    Letter from Turco Regarding Article, "Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial".
    Circulation. 2016;134:e179-80.
    PubMed     Text format    


    August 2016
  43. WASSNIG NK, Gunther M, Quick S, Pfluecke C, et al
    Experience With the Wearable Cardioverter-Defibrillator in Patients at High Risk for Sudden Cardiac Death.
    Circulation. 2016;134:635-43.
    PubMed     Text format     Abstract available


  44. OLDGREN J, Hijazi Z, Lindback J, Alexander JH, et al
    Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial Fibrillation.
    Circulation. 2016 Aug 28. pii: CIRCULATIONAHA.116.022802.
    PubMed     Text format     Abstract available


  45. WILDE AA, Moss AJ, Kaufman ES, Shimizu W, et al
    Clinical Aspects of Type 3 Long QT Syndrome: An International Multicenter Study.
    Circulation. 2016 Aug 26. pii: CIRCULATIONAHA.116.021823.
    PubMed     Text format     Abstract available


  46. BARALLOBRE-BARREIRO J, Gupta SK, Zoccarato A, Kitazume-Taneike R, et al
    Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation.
    Circulation. 2016 Aug 24. pii: CIRCULATIONAHA.115.016423.
    PubMed     Text format     Abstract available


  47. NORBY FL, Soliman EZ, Chen LY, Bengtson LG, et al
    Trajectories of Cardiovascular Risk Factors and Incidence of Atrial Fibrillation Over a 25-Year Follow-Up: The ARIC Study (Atherosclerosis Risk in Communities).
    Circulation. 2016;134:599-610.
    PubMed     Text format     Abstract available


  48. SHARKEY SW, Orlandi Q, Olivari MT
    Response by Sharkey et al to Letter Regarding Article, "Giant J Waves and ST-Segment Elevation Associated With Acute Gastric Distension".
    Circulation. 2016;134:e111-2.
    PubMed     Text format    


  49. LITTMANN L
    Letter by Littmann Regarding Article, "Giant J Waves and ST-Segment Elevation Associated With Acute Gastric Distension".
    Circulation. 2016;134:e109-10.
    PubMed     Text format    


  50. REIFFEL JA
    ECG Response: Can You Make The Correct Morphology, Pathology, and Rhythm Diagnoses?
    Circulation. 2016;134:567-9.
    PubMed     Text format    


  51. EZEKOWITZ MD, Nagarakanti R, Noack H, Brueckmann M, et al
    Comparison of Dabigatran versus Warfarin in Patients with Atrial Fibrillation and Valvular Heart Disease: The RE-LY Trial.
    Circulation. 2016 Aug 5. pii: CIRCULATIONAHA.115.020950.
    PubMed     Text format     Abstract available


  52. HESS PL, Hernandez AF, Bhatt DL, Hellkamp AS, et al
    Sex and Race/Ethnicity Differences in Implantable Cardioverter-Defibrillator Counseling and Use Among Patients Hospitalized With Heart Failure: Findings from the Get With The Guidelines-Heart Failure Program.
    Circulation. 2016 Aug 4. pii: CIRCULATIONAHA.115.021048.
    PubMed     Text format     Abstract available


  53. LIP GY
    Response by Lip to Letter Regarding Article, "How to Manage Occult Atrial Fibrillation Detected on Long-Term Monitoring".
    Circulation. 2016;134:e30-1.
    PubMed     Text format    


  54. HESS PL, Lopes RD, Healey JS
    Letter by Hess et al Regarding Article, "How to Manage Occult Atrial Fibrillation Detected on Long-Term Monitoring".
    Circulation. 2016;134:e28-9.
    PubMed     Text format    


    July 2016
  55. LI N, Csepe TA, Hansen BJ, Sul LV, et al
    Adenosine-Induced Atrial Fibrillation: Localized Reentrant Drivers in Lateral Right Atria due to Heterogeneous Expression of Adenosine A1 Receptors and GIRK4 Subunits in the Human Heart.
    Circulation. 2016 Jul 26. pii: CIRCULATIONAHA.115.021165.
    PubMed     Text format     Abstract available


  56. LINK MS, Haissaguerre M, Natale A
    Ablation of Atrial Fibrillation: Patient Selection, Periprocedural Anticoagulation, Techniques, and Preventive Measures After Ablation.
    Circulation. 2016;134:339-52.
    PubMed     Text format     Abstract available


  57. ANTER E, Tschabrunn CM, Buxton AE, Josephson ME, et al
    High-Resolution Mapping of Postinfarction Reentrant Ventricular Tachycardia: Electrophysiological Characterization of the Circuit.
    Circulation. 2016;134:314-27.
    PubMed     Text format     Abstract available


  58. HE VY, Condon JR, Ralph AP, Zhao Y, et al
    Long-Term Outcomes From Acute Rheumatic Fever and Rheumatic Heart Disease: A Data-Linkage and Survival Analysis Approach.
    Circulation. 2016;134:222-32.
    PubMed     Text format     Abstract available


  59. PICCINI JP, Hellkamp AS, Washam JB, Becker RC, et al
    Response by Piccini et al to Letters Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation".
    Circulation. 2016;134:e7-8.
    PubMed     Text format    


  60. IMPRIALOS K, Boutari C, Stavropoulos K
    Letter by Imprialos et al Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation".
    Circulation. 2016;134:e5-6.
    PubMed     Text format    


  61. BOUATOU Y, El Biali M, Samer CF
    Letter by Bouatou et al Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation".
    Circulation. 2016;134:e3-4.
    PubMed     Text format    


  62. HIJAZI Z, Wallentin L
    Renal Function in Atrial Fibrillation: A Multifaceted Dilemma.
    Circulation. 2016;134:48-51.
    PubMed     Text format    


  63. FORDYCE CB, Hellkamp AS, Lokhnygina Y, Lindner SM, et al
    On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF.
    Circulation. 2016;134:37-47.
    PubMed     Text format     Abstract available


  64. BOHULA EA, Giugliano RP, Ruff CT, Kuder JF, et al
    Impact of Renal Function on Outcomes With Edoxaban in the ENGAGE AF-TIMI 48 Trial.
    Circulation. 2016;134:24-36.
    PubMed     Text format     Abstract available


    June 2016
  65. ALBERT CM, Stevenson WG
    The Future of Arrhythmias and Electrophysiology.
    Circulation. 2016;133:2687-96.
    PubMed     Text format    


  66. WILLIS BC, Pandit SV, Ponce-Balbuena D, Zarzoso M, et al
    Constitutive Intracellular Na+ Excess in Purkinje Cells Promotes Arrhythmogenesis at Lower Levels of Stress Than Ventricular Myocytes From Mice With Catecholaminergic Polymorphic Ventricular Tachycardia.
    Circulation. 2016;133:2348-59.
    PubMed     Text format     Abstract available


  67. SANTHANAKRISHNAN R, Wang N, Larson MG, Magnani JW, et al
    Response to Letter Regarding Article, "Atrial Fibrillation Begets Heart Failure and Vice Versa: Temporal Associations and Differences in Preserved Versus Reduced Ejection Fraction".
    Circulation. 2016;133:e692-3.
    PubMed     Text format    


  68. PROVIDENCIA R, Lambiase PD
    Letter by Providencia and Lambiase Regarding Article, "Atrial Fibrillation Begets Heart Failure and Vice Versa: Temporal Associations and Differences in Preserved Versus Reduced Ejection Fraction".
    Circulation. 2016;133:e691.
    PubMed     Text format    


    May 2016
  69. MACINTYRE C, Lakdawala NK
    Management of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
    Circulation. 2016;133:1901-5.
    PubMed     Text format    


  70. MCMURRAY JJ
    Disease Management Programs in Cardiology: Extending the Success in Failure.
    Circulation. 2016;133:1836-7.
    PubMed     Text format    


  71. JOHN RM, Kumar S
    Sinus Node and Atrial Arrhythmias.
    Circulation. 2016;133:1892-900.
    PubMed     Text format     Abstract available


  72. ALVAREZ-GARCIA J, Vives-Borras M, Gomis P, Ordonez-Llanos J, et al
    Electrophysiological Effects of Selective Atrial Coronary Artery Occlusion in Humans.
    Circulation. 2016 May 5. pii: CIRCULATIONAHA.116.021700.
    PubMed     Text format     Abstract available



  73. ECG Response: May 3, 2016.
    Circulation. 2016;133:1827.
    PubMed     Text format    


    April 2016

  74. ECG Response: April 19, 2016.
    Circulation. 2016;133:1625-6.
    PubMed     Text format    


  75. WAKS JW, Sitlani CM, Soliman EZ, Kabir M, et al
    Global Electrical Heterogeneity Risk Score for Prediction of Sudden Cardiac Death in the General Population: The Atherosclerosis Risk in Communities (ARIC) and Cardiovascular Health (CHS) Studies.
    Circulation. 2016 Apr 14. pii: CIRCULATIONAHA.116.021306.
    PubMed     Text format     Abstract available


  76. KUMAR S, Sparks PB, Kalman JM
    Letter by Kumar et al Regarding Article, "Extensive Intramural Esophageal Hematoma After Transesophageal Echocardiography During Atrial Fibrillation Ablation".
    Circulation. 2016;133:e594.
    PubMed     Text format    


  77. QAMAR A, Bhatt DL
    Stroke Prevention in Atrial Fibrillation in Patients With Chronic Kidney Disease.
    Circulation. 2016;133:1512-5.
    PubMed     Text format    


  78. SAVINO JA 3RD, Halperin JL
    Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? The CHA2 DS2-VASc 1 Conundrum: Decision Making at the Lower End of the Risk Spectrum.
    Circulation. 2016;133:1504-11.
    PubMed     Text format    


  79. LIP GY, Nielsen PB
    Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? Yes: Even 1 Stroke Risk Factor Confers a Real Risk of Stroke.
    Circulation. 2016;133:1498-503.
    PubMed     Text format    


  80. PATTON KK, Ellinor PT, Ezekowitz M, Kowey P, et al
    Electrocardiographic Early Repolarization: A Scientific Statement From the American Heart Association.
    Circulation. 2016;133:1520-9.
    PubMed     Text format    


  81. DE LAZZARI M, Fedrigo M, Migliore F, Cianci A, et al
    Nonamyloidotic Light Chain Cardiomyopathy: The Arrhythmogenic Magnetic Resonance Pattern.
    Circulation. 2016;133:1421-3.
    PubMed     Text format    



  82. ECG Response: April 5, 2016.
    Circulation. 2016;133:1419-20.
    PubMed     Text format    


  83. PAGE RL, Joglar JA, Caldwell MA, Calkins H, et al
    2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
    Circulation. 2016;133:e506-74.
    PubMed     Text format    


  84. PAGE RL, Joglar JA, Caldwell MA, Calkins H, et al
    2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rh
    Circulation. 2016;133:e471-505.
    PubMed     Text format    


  85. AL-KHATIB SM, Arshad A, Balk EM, Das SR, et al
    Risk Stratification for Arrhythmic Events in Patients With Asymptomatic Pre-Excitation: A Systematic Review for the 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of
    Circulation. 2016;133:e575-86.
    PubMed     Text format     Abstract available


    March 2016
  86. DI BIASE L, Mohanty P, Mohanty S, Santangeli P, et al
    Ablation vs. Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial.
    Circulation. 2016 Mar 30. pii: CIRCULATIONAHA.115.019406.
    PubMed     Text format     Abstract available


  87. KOPLAN BA, Stevenson WG
    Atrial Fibrillation in Heart Failure: Should Catheter Ablation Play a Larger Role?
    Circulation. 2016 Mar 30. pii: CIRCULATIONAHA.116.022261.
    PubMed     Text format     Abstract available


  88. LIP GY
    How to Manage Occult Atrial Fibrillation Detected on Long-Term Monitoring.
    Circulation. 2016;133:1290-5.
    PubMed     Text format    


  89. BASSO C, Marra MP, Rizzo S, De Lazzari M, et al
    Response to Letters Regarding Article, "Arrhythmic Mitral Valve Prolapse and Sudden Cardiac Death".
    Circulation. 2016;133:e460.
    PubMed     Text format    


  90. PROVIDENCIA R, Lambiase PD
    Letter by Providencia and Lambiase Regarding Article, "Arrhythmic Mitral Valve Prolapse and Sudden Cardiac Death".
    Circulation. 2016;133:e459.
    PubMed     Text format    


  91. SHEPPARD MN, Steriotis AK, Sharma S
    Letter by Sheppard et al Regarding Article, "Arrhythmic Mitral Valve Prolapse and Sudden Cardiac Death".
    Circulation. 2016;133:e458.
    PubMed     Text format    


  92. KRAMER DB, Reynolds MR, Normand SL, Parzynski CS, et al
    Hospice Use Following Implantable Cardioverter-Defibrillator Implantation in Older Patients: Results From the NCDR(R).
    Circulation. 2016 Mar 25. pii: CIRCULATIONAHA.115.020677.
    PubMed     Text format     Abstract available



  93. ECG Response: March 22, 2016.
    Circulation. 2016;133:1217.
    PubMed     Text format    


  94. ADAY AW, Sobieszczyk PS, Beckman JA
    Absent at Birth: An Unusual Case of Deep Vein Thrombosis.
    Circulation. 2016;133:1209-16.
    PubMed     Text format    


  95. SCHMIDT C, Wiedmann F, Voigt N, Zhou XB, et al
    Response to Letter Regarding Article, "Upregulation of K2P3.1 K+ Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation".
    Circulation. 2016;133:e440-1.
    PubMed     Text format    


  96. OLSCHEWSKI A, Chandran N, Olschewski H
    Letter by Olschewski et al Regarding Article, "Upregulation of K2P3.1 K+ Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation".
    Circulation. 2016;133:e439.
    PubMed     Text format    


  97. CORRADO D, Wichter T, Link MS, Hauer R, et al
    Response to Letter Regarding Article, "Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: An International Task Force Consensus Statement".
    Circulation. 2016;133:e437-8.
    PubMed     Text format    


  98. BARISON A, Todiere G, Aquaro GD
    Letter by Barison et al Regarding Article, "Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: An International Task Force Consensus Statement".
    Circulation. 2016;133:e436.
    PubMed     Text format    


  99. HIBBS J, Orlandi Q, Olivari MT, Dickey W, et al
    Giant J Waves and ST-Segment Elevation Associated With Acute Gastric Distension.
    Circulation. 2016;133:1132-4.
    PubMed     Text format    


  100. CHAO TF, Liu CJ, Liao JN, Wang KL, et al
    The Use of Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation Patients with History of Intra-Cranial Hemorrhage.
    Circulation. 2016 Mar 11. pii: CIRCULATIONAHA.115.019794.
    PubMed     Text format     Abstract available


  101. GOLDBERGER JJ, Arora R, Green D, Greenland P, et al
    Response to Letter Regarding Article, "Evaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic Substrate".
    Circulation. 2016;133:e431.
    PubMed     Text format    


  102. JOGIA D, Liang M
    Letter by Jogia and Liang Regarding Article, "Evaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic Substrate".
    Circulation. 2016;133:e430.
    PubMed     Text format    



  103. ECG Response: March 8, 2016.
    Circulation. 2016;133:1047.
    PubMed     Text format    


    February 2016

  104. ECG Response: February 23, 2016.
    Circulation. 2016;133:764.
    PubMed     Text format    


  105. HAEGELI LM, Della Bella P, Brunckhorst CB
    Management of a Patient With Electrical Storm: Role of Epicardial Catheter Ablation.
    Circulation. 2016;133:672-6.
    PubMed     Text format    


  106. SROUBEK J, Probst V, Mazzanti A, Delise P, et al
    Programmed Ventricular Stimulation for Risk Stratification in the Brugada Syndrome: A Pooled Analysis.
    Circulation. 2016;133:622-30.
    PubMed     Text format     Abstract available


  107. DAOUD EG
    Even a Pooled Analysis Does Not Resolve the Debate of Electrophysiology Testing in Brugada Syndrome.
    Circulation. 2016;133:619-21.
    PubMed     Text format    


  108. HONDA S, Kawasaki T, Shiraishi H, Yamano M, et al
    Mitral Valve Prolapse Revisited.
    Circulation. 2016;133:e380-2.
    PubMed     Text format    



  109. ECG Response: February 9, 2016.
    Circulation. 2016;133:610-1.
    PubMed     Text format    


    January 2016
  110. DE FERRARI GM, Dusi V, Spazzolini C, Bos JM, et al
    Response to Letters Regarding Article, "Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation".
    Circulation. 2016;133:e366-7.
    PubMed     Text format    


  111. GOW RM
    Letter by Gow Regarding Article, "Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation".
    Circulation. 2016;133:e365.
    PubMed     Text format    


  112. PATANE S
    Letter by Patane Regarding Article, "Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation".
    Circulation. 2016;133:e364.
    PubMed     Text format    



  113. ECG Response: January 26, 2016.
    Circulation. 2016;133:442-3.
    PubMed     Text format    


  114. ELAGHA AA, Weissman G
    Pacemaker Malfunction Attributed to Multidetector Cardiac Computed Tomography.
    Circulation. 2016;133:342-3.
    PubMed     Text format    


  115. PADFIELD GJ, Escudero CA, De Souza AM, Steinberg C, et al
    Characterization of Myocardial Repolarization Reserve in Adolescent Females with Anorexia Nervosa.
    Circulation. 2016 Jan 14. pii: CIRCULATIONAHA.115.016697.
    PubMed     Text format     Abstract available



  116. ECG Response: January 12, 2016.
    Circulation. 2016;133:232-3.
    PubMed     Text format    


  117. SANTHANAKRISHNAN R, Wang N, Larson MG, Magnani JW, et al
    Atrial Fibrillation Begets Heart Failure and Vice Versa: Temporal Associations and Differences in Preserved vs. Reduced Ejection Fraction.
    Circulation. 2016 Jan 8. pii: CIRCULATIONAHA.115.018614.
    PubMed     Text format     Abstract available


  118. OLEN MM, Baysa SJ, Rossi A, Kanter RJ, et al
    Wolff-Parkinson-White Syndrome: A Stepwise Deterioration to Sudden Death.
    Circulation. 2016;133:105-6.
    PubMed     Text format    


  119. MALMO V, Nes BM, Amundsen BH, Tjonna AE, et al
    Aerobic Interval Training Reduces the Burden of Atrial Fibrillation in the Short Term: A Randomized Trial.
    Circulation. 2016 Jan 5. pii: CIRCULATIONAHA.115.018220.
    PubMed     Text format     Abstract available


  120. ELLIOTT AD, Mahajan R, Pathak RK, Lau DH, et al
    Exercise Training and Atrial Fibrillation: Further Evidence for the Importance of Lifestyle Change.
    Circulation. 2016 Jan 5. pii: CIRCULATIONAHA.115.020800.
    PubMed     Text format     Abstract available


    December 2015
  121. QURESHI WT, Alirhayim Z, Blaha MJ, Juraschek SP, et al
    Response to Letter Regarding Article, "Cardiorespiratory Fitness and Risk of Incident Atrial Fibrillation: Results From the Henry Ford Exercise Testing (FIT) Project".
    Circulation. 2015;132:e395.
    PubMed     Text format    


  122. PATANE S
    Letter by Patane Regarding Article, "Cardiorespiratory Fitness and Risk of Incident Atrial Fibrillation: Results From the Henry Ford Exercise Testing (FIT) Project".
    Circulation. 2015;132:e394.
    PubMed     Text format    


  123. SARDANA M
    Letter by Sardana Regarding Article, "Long-Term Outcomes of Secondary Atrial Fibrillation in the Community: The Framingham Heart Study".
    Circulation. 2015;132:e393.
    PubMed     Text format    


  124. PATEL MR, Piccini JP
    The Need to Evaluate Net Clinical Effect of Stroke Prevention Therapy in Patients with End Stage Renal Disease and Atrial Fibrillation.
    Circulation. 2015 Dec 17. pii: CIRCULATIONAHA.115.020378.
    PubMed     Text format     Abstract available


  125. SHIH CJ, Ou SM, Chao PW, Kuo SC, et al
    Risks of Death and Stroke in Patients Undergoing Hemodialysis With New-Onset Atrial Fibrillation: A Competing-Risk Analysis of a Nationwide Cohort.
    Circulation. 2015 Dec 17. pii: CIRCULATIONAHA.115.018294.
    PubMed     Text format     Abstract available


  126. PICCINI JP, Hellkamp AS, Washam JB, Becker RC, et al
    Polypharmacy and the Efficacy and Safety of Rivaroxaban versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation.
    Circulation. 2015 Dec 16. pii: CIRCULATIONAHA.115.018544.
    PubMed     Text format     Abstract available


  127. DOUGHERTY CM, Glenny RW, Burr RL, Flo GL, et al
    Response to Letter Regarding Article, "Prospective Randomized Trial of Moderately Strenuous Aerobic Exercise After an Implantable Cardioverter Defibrillator".
    Circulation. 2015;132:e381.
    PubMed     Text format    


  128. AYOUB K
    Letter by Ayoub Regarding Article, "Prospective Randomized Trial of Moderately Strenuous Aerobic Exercise After an Implantable Cardioverter Defibrillator".
    Circulation. 2015;132:e380.
    PubMed     Text format    


  129. LINDVALL C, Chatterjee NA, Chang Y, Chernack B, et al
    National Trends in the Utilization of Cardiac Resynchronization Therapy With or Without Implantable-Cardioverter Defibrillator.
    Circulation. 2015 Dec 3. pii: CIRCULATIONAHA.115.018830.
    PubMed     Text format     Abstract available


  130. ABDUL-RAHIM AH, Perez AC, Fulton RL, Jhund PS, et al
    Response to Letter Regarding Article, "Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopr
    Circulation. 2015;132:e358.
    PubMed     Text format    


  131. LIN GM, Hung Y, Li YH
    Letter by Lin et al Regarding Article, "Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sop
    Circulation. 2015;132:e357.
    PubMed     Text format    


  132. MARON BJ, Udelson JE, Bonow RO, Nishimura RA, et al
    Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scie
    Circulation. 2015;132:e273-80.
    PubMed     Text format    


  133. LINK MS, Mark Estes NA 3rd, Maron BJ
    Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 13: Commotio Cordis: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Circulation. 2015;132:e339-42.
    PubMed     Text format    


  134. ZIPES DP, Link MS, Ackerman MJ, Kovacs RJ, et al
    Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 9: Arrhythmias and Conduction Defects: A Scientific Statement From the American Heart Association and American College of Cardiolog
    Circulation. 2015;132:e315-25.
    PubMed     Text format    


    November 2015
  135. SARRIAS A, Villuendas R, Bisbal F, Pereferrer D, et al
    From Atrial Fibrillation to Ventricular Fibrillation and Back.
    Circulation. 2015;132:2035-6.
    PubMed     Text format    


  136. KIM MY, Ng FS, Ariff B, Hanna GB, et al
    Extensive Intramural Esophageal Hematoma After Transesophageal Echocardiography During Atrial Fibrillation Ablation.
    Circulation. 2015;132:1847-9.
    PubMed     Text format    


  137. PODRID PJ
    ECG Response: November 10, 2015.
    Circulation. 2015;132:1846.
    PubMed     Text format    


  138. KANEKO Y, Naito S, Okishige K, Morishima I, et al
    Atypical Fast-Slow Atrioventricular Nodal Reentrant Tachycardia Incorporating a "Superior" Slow Pathway: A Distinct Supraventricular Tachyarrhythmia.
    Circulation. 2015 Nov 5. pii: CIRCULATIONAHA.115.018443.
    PubMed     Text format     Abstract available


  139. DE CAEN AR, Berg MD, Chameides L, Gooden CK, et al
    Part 12: Pediatric Advanced Life Support: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2015;132.
    PubMed     Text format    


  140. LINK MS, Berkow LC, Kudenchuk PJ, Halperin HR, et al
    Part 7: Adult Advanced Cardiovascular Life Support: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2015;132.
    PubMed     Text format    


    October 2015
  141. COLIN GC, Vancraeynest D, Hoton D, Jonard P, et al
    Complete heart block caused by diffuse pseudotumoral cardiac involvement in granulomatosis with polyangiitis.
    Circulation. 2015;132:e207-10.
    PubMed     Text format    



  142. ECG response: October 27, 2015.
    Circulation. 2015;132:1679-80.
    PubMed     Text format    


  143. KUTYIFA V, Moss AJ, Klein H, Biton Y, et al
    Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry).
    Circulation. 2015;132:1613-9.
    PubMed     Text format     Abstract available


  144. AGUILAR M, Xiong F, Qi XY, Comtois P, et al
    Potassium Channel Blockade Enhances Atrial Fibrillation-Selective Antiarrhythmic Effects of Optimized State-Dependent Sodium Channel Blockade.
    Circulation. 2015 Oct 23. pii: CIRCULATIONAHA.115.018016.
    PubMed     Text format     Abstract available


  145. LEE S, Sahadevan J, Khrestian CM, Cakulev I, et al
    Simultaneous Bi-Atrial High Density (510 - 512 electrodes) Epicardial Mapping of Persistent and Long-Standing Persistent Atrial Fibrillation in Patients: New Insights into the Mechanism of Its Maintenance.
    Circulation. 2015 Oct 23. pii: CIRCULATIONAHA.115.017007.
    PubMed     Text format     Abstract available


  146. DE BAKKER JM, van Dessel PF
    Long-Standing Persistent Atrial Fibrillation: Can We Distinguish Ectopic Activity From Reentry by Epicardial Mapping?
    Circulation. 2015 Oct 23. pii: CIRCULATIONAHA.115.019417.
    PubMed     Text format     Abstract available


  147. KOWEY PR, Robinson VM
    Smoothing the Bumpy Road to Antiarrhythmic Drug Development.
    Circulation. 2015 Oct 23. pii: CIRCULATIONAHA.115.019463.
    PubMed     Text format     Abstract available


  148. TRAVERS AH, Perkins GD, Berg RA, Castren M, et al
    Part 3: Adult Basic Life Support and Automated External Defibrillation: 2015 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.
    Circulation. 2015;132.
    PubMed     Text format    


  149. HAZINSKI MF, Nolan JP, Aickin R, Bhanji F, et al
    Part 1: Executive Summary: 2015 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.
    Circulation. 2015;132.
    PubMed     Text format    


  150. FAGGIONI M, Knollmann BC
    Arrhythmia Protection in Hypokalemia: A Novel Role of Ca2+-Activated K+ Currents in the Ventricle.
    Circulation. 2015;132:1371-3.
    PubMed     Text format    


  151. CHAN YH, Tsai WC, Ko JS, Yin D, et al
    Small-Conductance Calcium-Activated Potassium Current Is Activated During Hypokalemia and Masks Short-Term Cardiac Memory Induced by Ventricular Pacing.
    Circulation. 2015;132:1377-86.
    PubMed     Text format     Abstract available


  152. LAVINE JB
    Letter by Lavine Regarding Article, "Cardiovascular, Bleeding, and Mortality Risks in Elderly Medicare Patients Treated With Dabigatran or Warfarin for Nonvalvular Atrial Fibrillation".
    Circulation. 2015;132:e179.
    PubMed     Text format    


  153. BARRAL M, Gandjbakhch E, Fouret JP, Aubart FC, et al
    Right Ventricular Hypertrophy Along With Malignant Ventricular Arrhythmias: An Uncommon Case of Sarcoidosis at Cardiac Magnetic Resonance Imaging.
    Circulation. 2015;132:e170-5.
    PubMed     Text format    


  154. PODRID PJ
    ECG Response: October 6, 2015.
    Circulation. 2015;132:1365.
    PubMed     Text format    


    September 2015

  155. ECG Response: September 22, 2015.
    Circulation. 2015;132:1152-3.
    PubMed     Text format    


  156. POTERUCHA TJ, Bergmark B, Aranki S, Kaneko T, et al
    Surgical Pulmonary Embolectomy.
    Circulation. 2015;132:1146-51.
    PubMed     Text format    


  157. VAN GELDER IC, Hobbelt A, Mulder BA, Rienstra M, et al
    Rate Control in Atrial Fibrillation: Many Questions Still Unanswered.
    Circulation. 2015 Sep 17. pii: CIRCULATIONAHA.115.018952.
    PubMed     Text format     Abstract available


  158. CHAO TF, Liu CJ, Tuan TC, Chen SJ, et al
    Rate-Control Treatment and Mortality in Atrial Fibrillation.
    Circulation. 2015 Sep 17. pii: CIRCULATIONAHA.114.013709.
    PubMed     Text format     Abstract available


  159. REA TD
    Science of Cardiopulmonary Resuscitation: Just Scratching the Surface.
    Circulation. 2015;132:994-6.
    PubMed     Text format    


  160. MARTINEZ-GONZALEZ MA, Toledo E, Aros F, Fiol M, et al
    Response to Letter Regarding Article, "Extravirgin Olive Oil Consumption Reduces Risk of Atrial Fibrillation: The PREDIMED (Prevencion con Dieta Mediterranea) Trial".
    Circulation. 2015;132:e140-2.
    PubMed     Text format    


  161. GONZALEZ-SALVADO V, Raposeiras-Roubin S, Gonzalez-Juanatey JR
    Letter by Gonzalez-Salvado et al Regarding Article, "Extravirgin Olive Oil Consumption Reduces Risk of Atrial Fibrillation: The PREDIMED (Prevencion con Dieta Mediterranea) Trial".
    Circulation. 2015;132:e139.
    PubMed     Text format    


  162. YAMAGUCHI J, Miyamoto T, Arai Y, Hirao T, et al
    Shock After Successful Primary Percutaneous Coronary Intervention for Ventricular Fibrillation.
    Circulation. 2015;132:e135-6.
    PubMed     Text format    


  163. TASKESEN T, Goldberg SL, Mannelli L, Rabkin D, et al
    Granulomatosis With Polyangiitis Presenting With an Intracardiac Mass and Complete Heart Block: Enhanced Images by 3-Dimensional Echocardiography.
    Circulation. 2015;132:961-4.
    PubMed     Text format    



  164. ECG Response: September 8, 2015.
    Circulation. 2015;132:960.
    PubMed     Text format    


  165. CALKINS H
    Demonstrating the Value of Contact Force Sensing: More Difficult Than Meets the Eye.
    Circulation. 2015;132:901-3.
    PubMed     Text format    


    August 2015

  166. ECG Response: August 18, 2015.
    Circulation. 2015;132:611-2.
    PubMed     Text format    


  167. GLYNN P, Musa H, Wu X, Unudurthi SD, et al
    Voltage-Gated Sodium Channel Phosphorylation at Ser571 Regulates Late Current, Arrhythmia, and Cardiac Function In Vivo.
    Circulation. 2015;132:567-77.
    PubMed     Text format     Abstract available


  168. MAKIELSKI JC, Kyle JW
    Late I(Na) in the Heart: Physiology, Pathology, and Pathways.
    Circulation. 2015;132:553-5.
    PubMed     Text format    


  169. LUIK A, Radzewitz A, Kieser M, Walter M, et al
    Cryoballoon versus Open Irrigated Radiofrequency Ablation in Patients With Paroxysmal Atrial Fibrillation: The Prospective, Randomised, Controlled, Non-Inferiority FreezeAF Study.
    Circulation. 2015 Aug 17. pii: CIRCULATIONAHA.115.016871.
    PubMed     Text format     Abstract available


  170. PIZZI MN, Roque A, Fernandez-Hidalgo N, Cuellar-Calabria H, et al
    Improving the Diagnosis of Infective Endocarditis in Prosthetic Valves and Intracardiac Devices with 18F-FDG-PET/CT-Angiography: Initial Results at an Infective Endocarditis Referral Center.
    Circulation. 2015 Aug 14. pii: CIRCULATIONAHA.115.015316.
    PubMed     Text format     Abstract available


  171. PEZHOUMAN A, Singh N, Song Z, Nivala M, et al
    Molecular Basis of Hypokalemia-Induced Ventricular Fibrillation.
    Circulation. 2015 Aug 12. pii: CIRCULATIONAHA.115.016217.
    PubMed     Text format     Abstract available


  172. SAGUNER AM, Buchmann B, Wyler D, Manka R, et al
    Arrhythmogenic Left Ventricular Cardiomyopathy: Suspected by Cardiac Magnetic Resonance Imaging, Confirmed by Identification of a Novel Plakophilin-2 Variant.
    Circulation. 2015;132:e38-40.
    PubMed     Text format    


  173. KOWALCZYK M, Kowalski M, Konka M, Michalowska I, et al
    A Heart With Quadruple Atria: Does it Exist?
    Circulation. 2015;132:547-8.
    PubMed     Text format    


  174. DE BIASI AR, Seastedt KP, Eachempati SR, Salemi A, et al
    Common Cause of Mortality in Trauma but Manageable Nonetheless.
    Circulation. 2015;132:537-45.
    PubMed     Text format    


  175. REDDY VY, Dukkipati SR, Neuzil P, Natale A, et al
    A Randomized Controlled Trial of the Safety and Effectiveness of a Contact Force Sensing Irrigated Catheter for Ablation of Paroxysmal Atrial Fibrillation: Results of the TOCCASTAR Study.
    Circulation. 2015 Aug 10. pii: CIRCULATIONAHA.114.014092.
    PubMed     Text format     Abstract available


  176. BROUWER TF, Walker RG, Chapman FW, Koster RW, et al
    Association Between Chest Compression Interruptions and Clinical Outcomes of Ventricular Fibrillation Out-of-Hospital Cardiac Arrest.
    Circulation. 2015 Aug 7. pii: CIRCULATIONAHA.115.014016.
    PubMed     Text format     Abstract available



  177. ECG Response: August 4, 2015.
    Circulation. 2015;132:454.
    PubMed     Text format    


    July 2015
  178. SEIFFGE DJ, Van Hooff RJ, Nolte CH, Bejot Y, et al
    Recanalization Therapies in Acute Ischemic Stroke Patients: Impact of Prior Treatment with Novel Oral Anticoagulants on Bleeding Complications and Outcome - A Pilot Study.
    Circulation. 2015 Jul 31. pii: CIRCULATIONAHA.115.015484.
    PubMed     Text format     Abstract available


  179. CHATTERJEE NA, Lubitz SA
    Systemic Embolic Events (SEE) in Atrial Fibrillation: SEEing Embolic Risk More Clearly.
    Circulation. 2015 Jul 29. pii: CIRCULATIONAHA.115.018172.
    PubMed     Text format     Abstract available


  180. BEKWELEM W, Connolly SJ, Halperin JL, Adabag S, et al
    Extracranial Systemic Embolic Events in Patients with Nonvalvular Atrial Fibrillation: Incidence, Risk Factors, and Outcomes.
    Circulation. 2015 Jul 29. pii: CIRCULATIONAHA.114.013243.
    PubMed     Text format     Abstract available


  181. GOLDBERGER JJ, Arora R, Green D, Greenland P, et al
    Evaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic Substrate.
    Circulation. 2015;132:278-91.
    PubMed     Text format     Abstract available


  182. KOLODGIE FD, Virmani R, Finn AV, Romero ME, et al
    Embolic Myocardial Infarction as a Consequence of Atrial Fibrillation: A Prevailing Disease of the Future.
    Circulation. 2015;132:223-6.
    PubMed     Text format    


  183. SHIBATA T, Kawakami S, Noguchi T, Tanaka T, et al
    Prevalence, Clinical Features, and Prognosis of Acute Myocardial Infarction Attributable to Coronary Artery Embolism.
    Circulation. 2015;132:241-50.
    PubMed     Text format     Abstract available


  184. CORRADO D, Wichter T, Link MS, Hauer RN, et al
    Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: An International Task Force Consensus Statement.
    Circulation. 2015 Jul 27. pii: CIRCULATIONAHA.115.017944.
    PubMed     Text format    


  185. MAURA G, Blotiere PO, Bouillon K, Billionnet C, et al
    Comparison of the Short-Term Risk of Bleeding and Arterial Thromboembolic Events in Nonvalvular Atrial Fibrillation Patients Newly Treated With Dabigatran or Rivaroxaban versus Vitamin K Antagonists: A French Nationwide Propensity-Matched Cohort Study
    Circulation. 2015 Jul 21. pii: CIRCULATIONAHA.115.015710.
    PubMed     Text format     Abstract available



  186. ECG Response: July 21, 2015.
    Circulation. 2015;132:215-6.
    PubMed     Text format    


  187. NOSEWORTHY PA, Asirvatham SJ
    The Knot That Binds Mitral Valve Prolapse and Sudden Cardiac Death.
    Circulation. 2015 Jul 9. pii: CIRCULATIONAHA.115.017979.
    PubMed     Text format     Abstract available


  188. BASSO C, Perazzolo Marra M, Rizzo S, De Lazzari M, et al
    Arrhythmic Mitral Valve Prolapse and Sudden Cardiac Death.
    Circulation. 2015 Jul 9. pii: CIRCULATIONAHA.115.016291.
    PubMed     Text format     Abstract available



  189. ECG Response: July 7, 2015.
    Circulation. 2015;132:68-9.
    PubMed     Text format    


    June 2015
  190. AVEZUM A, Lopes RD, Schulte PJ, Lanas F, et al
    Apixaban Compared with Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Findings From the ARISTOTLE Trial.
    Circulation. 2015 Jun 23. pii: CIRCULATIONAHA.114.014807.
    PubMed     Text format     Abstract available


  191. HEALEY JS, Sandhu RK
    Are We Ready for Mass Screening to Detect Atrial Fibrillation?
    Circulation. 2015;131:2167-8.
    PubMed     Text format    


  192. DE FERRARI GM, Dusi V, Spazzolini C, Bos JM, et al
    Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation.
    Circulation. 2015;131:2185-93.
    PubMed     Text format     Abstract available


  193. NARAYANAN K, Chugh SS
    Sympathectomy for Patients With Catecholaminergic Polymorphic Ventricular Tachycardia: Should We Have the Nerve?
    Circulation. 2015;131:2169-71.
    PubMed     Text format    



  194. ECG Response: June 16, 2015.
    Circulation. 2015;131:2159-60.
    PubMed     Text format    


  195. NIELSEN PB, Larsen TB, Skjoth F, Gorst-Rasmussen A, et al
    Restarting Anticoagulant Treatment After Intracranial Haemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality and Bleeding: A Nationwide Cohort Study.
    Circulation. 2015 Jun 9. pii: CIRCULATIONAHA.115.015735.
    PubMed     Text format     Abstract available


  196. PRUTKIN JM, Reynolds MR, Bao H, Curtis JP, et al
    Response to letter regarding article, "rates of and factors associated with infection in 200 909 medicare implantable cardioverter-defibrillator implants: results from the national cardiovascular data registry".
    Circulation. 2015;131:e518.
    PubMed     Text format    


  197. LONGTIN Y, Connolly SJ, Krahn AD
    Letter by longtin et Al regarding article, "rates of and factors associated with infection in 200 909 medicare implantable cardioverter-defibrillator implants: results from the national cardiovascular data registry".
    Circulation. 2015;131:e517.
    PubMed     Text format    



  198. ECG Response: June 2, 2015.
    Circulation. 2015;131:2020.
    PubMed     Text format    


  199. ZHANG J, Sacher F, Hoffmayer K, O'Hara T, et al
    Cardiac electrophysiological substrate underlying the ECG phenotype and electrogram abnormalities in Brugada syndrome patients.
    Circulation. 2015;131:1950-9.
    PubMed     Text format     Abstract available


    May 2015
  200. BHATT AB, Foster E, Kuehl K, Alpert J, et al
    Congenital heart disease in the older adult: a scientific statement from the American Heart Association.
    Circulation. 2015;131:1884-931.
    PubMed     Text format    


  201. YUE Y, Castrichini M, Srivastava U, Fabris F, et al
    Pathogenesis of the Novel Autoimmune-Associated Long QT Syndrome.
    Circulation. 2015 May 20. pii: CIRCULATIONAHA.115.009800.
    PubMed     Text format     Abstract available


  202. SHARMA M, Cornelius VR, Patel JP, Davies JG, et al
    Efficacy and Harms of Direct Oral Anticoagulants in the Elderly for Stroke Prevention in Atrial Fibrillation and Secondary Prevention of Venous Thromboembolism: Systematic Review and Meta-Analysis.
    Circulation. 2015 May 20. pii: CIRCULATIONAHA.114.013267.
    PubMed     Text format     Abstract available


  203. PAPPONE C, Vicedomini G, Manguso F, Saviano M, et al
    Response to letter regarding article, "wolff-Parkinson-white syndrome in the era of catheter ablation: insights from a registry study of 2169 patients".
    Circulation. 2015;131:e499.
    PubMed     Text format    


  204. FENICI R, Brisinda D, Venuti A
    Letter by Fenici et al Regarding Articles, "Wolff-Parkinson-White Syndrome in the Era of Catheter Ablation: Insights From a Registry Study of 2169 Patients" and "The Asymptomatic Wolff-Parkinson-White Patient: Time to be More Proactive?".
    Circulation. 2015;131:e498.
    PubMed     Text format    


  205. OBEYESEKERE MN, Klein GJ
    Response to Letter Regarding Editorial, "The Asymptomatic Wolff-Parkinson-White Patient: Time to be More Proactive?".
    Circulation. 2015;131:e500.
    PubMed     Text format    



  206. ECG Response: May 19, 2015.
    Circulation. 2015;131:1804-5.
    PubMed     Text format    


  207. NUMATA S, Yaku H, Doi K, Yamazaki S, et al
    Excess anterior mitral leaflet in a patient with hypertrophic obstructive cardiomyopathy and systolic anterior motion.
    Circulation. 2015;131:1605-7.
    PubMed     Text format    



  208. ECG Response: May 5, 2015. Complete heart block. An escape ventricular rhythm.
    Circulation. 2015;131:1604.
    PubMed     Text format    


  209. MCNALLY EM, Kaltman JR, Benson DW, Canter CE, et al
    Contemporary cardiac issues in Duchenne muscular dystrophy. Working Group of the National Heart, Lung, and Blood Institute in collaboration with Parent Project Muscular Dystrophy.
    Circulation. 2015;131:1590-8.
    PubMed     Text format    


  210. MARIJON E, Bougouin W, Tafflet M, Karam N, et al
    Population movement and sudden cardiac arrest location.
    Circulation. 2015;131:1546-54.
    PubMed     Text format     Abstract available


    April 2015

  211. ECG Response: April 21, 2015. This is a pattern of Mobitz type I or Wenckebach.
    Circulation. 2015;131:1458.
    PubMed     Text format    


  212. MARIJON E, Uy-Evanado A, Reinier K, Teodorescu C, et al
    Sudden cardiac arrest during sports activity in middle age.
    Circulation. 2015;131:1384-91.
    PubMed     Text format     Abstract available


  213. SUZUKI K, Okada H, Fukuta T, Yoshida S, et al
    "Prancing" heart with pericardial injury.
    Circulation. 2015;131:e397-8.
    PubMed     Text format    



  214. ECG response: April 7, 2015.
    Circulation. 2015;131:1300-1.
    PubMed     Text format    


    March 2015
  215. WASEK WC, Samul W, Ryczek R, Skrobowski A, et al
    Unique Case of ST-Segment-Elevation Myocardial Infarction Related to Paradoxical Embolization and Simultaneous Pulmonary Embolization: Clinical Considerations on Indications for Patent Foramen Ovale Closure in No-Guidelines Land.
    Circulation. 2015;131:1214-23.
    PubMed     Text format    


  216. BERGMARK BA, Galper BZ, Shah AM, Bhatt DL, et al
    Myocardial Bridging in a Man With Non-ST-Elevation Myocardial Infarction.
    Circulation. 2015;131:e373-4.
    PubMed     Text format    



  217. ECG Response: March 10, 2015.
    Circulation. 2015;131:923-4.
    PubMed     Text format    


    February 2015
  218. LOSCALZO J
    Expression of concern.
    Circulation. 2015;131:e351.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: